{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:20Z","timestamp":1792783520524,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108129"],"award-info":[{"award-number":["JP20fk0108129"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21fk0108129h0802"],"award-info":[{"award-number":["21fk0108129h0802"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nagai Memorial Research Scholarship","award":["N202704"],"award-info":[{"award-number":["N202704"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-022-01757-3","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T13:02:42Z","timestamp":1643720562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Low-dosage ethambutol, less than 12.5\u00a0mg\/kg\/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-2249","authenticated-orcid":false,"given":"Fumiya","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Furuuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Uesugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuyuki","family":"Kurashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8239-9275","authenticated-orcid":false,"given":"Kozo","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"1","key":"1757_CR1","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535.","journal-title":"Eur Respir J"},{"issue":"6","key":"1757_CR2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3201\/eid2206.151086","volume":"22","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease. Japan Emerg Infect Dis. 2016;22(6):1116\u20137.","journal-title":"Japan Emerg Infect Dis"},{"issue":"2","key":"1757_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4046\/trd.2016.79.2.74","volume":"79","author":"YJ Ryu","year":"2016","unstructured":"Ryu YJ, Koh WJ, Daley CL. Diagnosis and treatment of nontuberculous mycobacterial lung disease: clinicians\u2019 perspectives. Tuberc Respir Dis (Seoul). 2016;79(2):74\u201384.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"1","key":"1757_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1378\/chest.77.1.98","volume":"77","author":"VS Nair","year":"1980","unstructured":"Nair VS, LeBrun M, Kass I. Peripheral neuropathy associated with ethambutol. Chest. 1980;77(1):98\u2013100.","journal-title":"Chest"},{"issue":"8","key":"1757_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2165\/11534340-000000000-00000","volume":"24","author":"JS Kass","year":"2010","unstructured":"Kass JS, Shandera WX. Nervous system effects of antituberculosis therapy. CNS Drugs. 2010;24(8):655\u201367.","journal-title":"CNS Drugs"},{"issue":"2","key":"1757_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1164\/rccm.200407-863OC","volume":"172","author":"DE Griffith","year":"2005","unstructured":"Griffith DE, Brown-Elliott BA, Shepherd S, McLarty J, Griffith L, Wallace RJ Jr. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2005;172(2):250\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1757_CR7","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1128\/AAC.45.6.1607-1614.2001","volume":"45","author":"KA Nash","year":"2001","unstructured":"Nash KA. Effect of drug concentration on emergence of macrolide resistance in Mycobacterium avium. Antimicrob Agents Chemother. 2001;45(6):1607\u201314.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1757_CR8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/infdis\/174.6.1218","volume":"174","author":"LE Bermudez","year":"1996","unstructured":"Bermudez LE, Nash KA, Petrofsky M, Young LS, Inderlied CB. Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. J Infect Dis. 1996;174(6):1218\u201322.","journal-title":"J Infect Dis"},{"issue":"8","key":"1757_CR9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","volume":"174","author":"DE Griffith","year":"2006","unstructured":"Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;174(8):928\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1757_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12890-019-0982-8","volume":"19","author":"HJ Kim","year":"2019","unstructured":"Kim HJ, Lee JS, Kwak N, Cho J, Lee CH, Han SK, et al. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease. BMC Pulm Med. 2019;19(1):212.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"1757_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1086\/514116","volume":"176","author":"MP Dub\u00e9","year":"1997","unstructured":"Dub\u00e9 MP, Sattler FR, Torriani FJ, See D, Havlir DV, Kemper CA, et al. A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group. J Infect Dis. 1997;176(5):1225\u201332.","journal-title":"J Infect Dis"},{"issue":"11","key":"1757_CR12","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1513\/AnnalsATS.201604-246OC","volume":"13","author":"K Morimoto","year":"2016","unstructured":"Morimoto K, Namkoong H, Hasegawa N, Nakagawa T, Morino E, Shiraishi Y, Nontuberculous Mycobacteriosis Japan Research Consortium, et al. Macrolide-resistant Mycobacterium avium complex lung disease: analysis of 102 consecutive cases. Ann Am Thorac Soc. 2016;13(11):1904\u201311.","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"1757_CR13","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.3346\/jkms.2020.35.e59","volume":"35","author":"YS Kwon","year":"2020","unstructured":"Kwon YS, Kwon BS, Kim OH, Park YE, Shim TS, Chong YP, et al. Treatment outcomes after discontinuation of ethambutol due to adverse events in Mycobacterium avium complex lung disease. J Korean Med Sci. 2020;35(9):e59.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"1757_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/14740338.5.5.615","volume":"5","author":"FW Fraunfelder","year":"2006","unstructured":"Fraunfelder FW, Sadun AA, Wood T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf. 2006;5(5):615\u20138.","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"1757_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/thx.41.10.737","volume":"41","author":"KM Citron","year":"1986","unstructured":"Citron KM, Thomas GO. Ocular toxicity from ethambutol. Thorax. 1986;41(10):737\u20139.","journal-title":"Thorax"},{"issue":"1","key":"1757_CR16","first-page":"56","volume":"12","author":"RY Chan","year":"2006","unstructured":"Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J. 2006;12(1):56\u201360.","journal-title":"Hong Kong Med J"},{"issue":"21","key":"1757_CR17","first-page":"00121","volume":"S2212\u20135345","author":"T Ando","year":"2021","unstructured":"Ando T, Kage H, Matsumoto Y, Zokumasu K, Nagase T. Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease. Respir Investig. 2021;S2212\u20135345(21):00121.","journal-title":"Respir Investig"},{"issue":"3","key":"1757_CR18","doi-asserted-by":"publisher","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","volume":"51","author":"J van Ingen","year":"2018","unstructured":"van Ingen J, Aksamit T, Andrejak C, B\u00f6ttger EC, Cambau E, Daley CL, for NTM-NET, et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J. 2018;51(3):1800170.","journal-title":"Eur Respir J"},{"issue":"6","key":"1757_CR19","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1128\/AAC.04577-14","volume":"59","author":"BY Lee","year":"2015","unstructured":"Lee BY, Kim S, Hong Y, Lee SD, Kim WS, Kim DS, et al. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease. Antimicrob Agents Chemother. 2015;59(6):2972\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1757_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/rccm.201408-1545OC","volume":"191","author":"BH Jeong","year":"2015","unstructured":"Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2015;191(1):96\u2013103.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1757_CR21","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/cid\/cix517","volume":"65","author":"N Kwak","year":"2017","unstructured":"Kwak N, Park J, Kim E, Lee CH, Han SK, Yim JJ. Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(7):1077\u201384.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1757_CR22","doi-asserted-by":"publisher","first-page":"1602503","DOI":"10.1183\/13993003.02503-2016","volume":"50","author":"WJ Koh","year":"2017","unstructured":"Koh WJ, Moon SM, Kim SY, Woo MA, Kim S, Jhun BW, et al. Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype. Eur Respir J. 2017;50(3):1602503.","journal-title":"Eur Respir J"},{"issue":"2","key":"1757_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1378\/chest.13-2538","volume":"146","author":"RJ Wallace Jr","year":"2014","unstructured":"Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, et al. Macrolide\/Azalide therapy for nodular\/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146(2):276\u201382.","journal-title":"Chest"},{"issue":"1","key":"1757_CR24","doi-asserted-by":"publisher","first-page":"e000434","DOI":"10.1136\/bmjresp-2019-000434","volume":"6","author":"T Nakagawa","year":"2019","unstructured":"Nakagawa T, Hashimoto H, Yagi M, Kogure Y, Sekimizu M, Saito AM, et al. Multicenter, open label, randomized controlled trial comparing intermittent versus daily treatment for noncavitary nodular\/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol. BMJ Open Respir Res. 2019;6(1):e000434.","journal-title":"BMJ Open Respir Res"},{"issue":"10","key":"1757_CR25","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.5588\/ijtld.14.0139","volume":"19","author":"J Min","year":"2015","unstructured":"Min J, Park J, Lee YJ, Kim SJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease. Int J Tuberc Lung Dis. 2015;19(10):1239\u201345.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"1757_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.chest.2019.12.016","volume":"157","author":"K Furuuchi","year":"2020","unstructured":"Furuuchi K, Morimoto K, Kurashima A, Fujiwara K, Nakamoto K, Tanaka Y, et al. Treatment duration and disease recurrence following the successful treatment of patients with Mycobacterium avium complex lung disease. Chest. 2020;157(6):1442\u20135.","journal-title":"Chest"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-022-01757-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T08:04:23Z","timestamp":1659081863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-022-01757-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":26,"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1007\/s15010-022-01757-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The institutional review board of Fukujuji Hospital (#20044) approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have approved the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}